ClinicalTrials.gov
public full text
Public Domain
Assessment of HPHC Exposure in Smokers Switching to THS/TP18 With Different Device Variants
This is a randomized, controlled, open-label, 6 parallel arms study to assess reduced exposure of biomarkers of exposure (BoE) of selected HPHC in smokers switching to TP18 (a prototype heated tobacco device) or THS relative to smokers who continue smoking CIG after 5 days of confinement period, followed by 2 days of pharmacokinetic (PK) period of single use of THS/TP18 and CIG, and followed by an ambulatory period.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- CSD201004: An Actual Use Study of P10 and P13 Nicotine Pouches Among U.S. Adult Smokers#802942
- Nicotine Pouch Pharmacokinetics Abuse Liability#1007504
- A Study to Characterize Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouches in Adult Cigarette Smokers#800827
- Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation#833583
- Comparative Effectiveness of Two Tobacco Cessation Interventions for Employees of Partners HealthCare, Inc.#869583
Record · ID 1101857
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive